Stanford University
Showing 16,611-16,620 of 36,179 Results
-
Chirag Kumar
Ph.D. Student in Environment and Resources, admitted Autumn 2025
BioChirag Kumar combines next-generation modeling tools with on-the-ground field research to provide actionable strategies that improve human health amidst environmental and migratory uncertainty. He is interested in causally unraveling the environmental factors driving infectious diseases to inform targeted interventions that mitigate those threats and how those insights can be directly shared with the public to empower individual-level change. To unravel complex human-environment-health systems, he has conducted on-the-ground field work and mechanistic biological analyses to provide key inputs into his models. His findings have been used to advocate for new World Health Organization vaccine recommendations against antimicrobial-resistant pathogens. Chirag previously served as a Biden-Harris US Digital Corps Data Fellow at the US CDC’s Center for Forecasting and Outbreak Analytics and on the Biden administration’s White House AI Forum. He graduated from Princeton University as a Smith-Newton Environmental Research Scholar where he concentrated in chemistry with minors in applied math, global health, and quantitative biology. He is supported by a National Science Foundation Graduate Research Fellowship.
-
Manoj Kumar
Postdoctoral Scholar, Radiology
Current Research and Scholarly InterestsI work on imaging-guided therapy using PET and MR imaging approaches. My academic training and background is in molecular imaging. During my doctoral training, I developed and validated a PET imaging approach for evaluating endocrine therapy responses in advanced breast cancer. My current research focuses on imaging tumor immune markers and responses to cancer immunotherapy. The goal is to develop new imaging toolboxes to monitor and guide treatment. Specifically, I employ antibodies, nanoparticles, and reporter genes for imaging and combinations of therapies to modulate and restore the body's suppressed immune functions against cancer cells. This is being done in collaboration with teams of researchers in early clinical development and teams in clinical practice.
